Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03474744
Title Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Christian Buske
Age Groups: adult | senior
Covered Countries DEU | AUT

No variant requirements are available.